To hear about similar clinical trials, please enter your email below
Trial Title:
Retrospective Study of Germ Cell Tumors of the Central Nervous System
NCT ID:
NCT05836701
Condition:
Germ Cell Tumor of CNS
Conditions: Official terms:
Neoplasms, Germ Cell and Embryonal
Central Nervous System Neoplasms
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Retrospective
Summary:
Retrospectively analyzing the epidemiological and clinical characteristics, treatment,
recurrence, prognosis and prognostic factors of the germ-cell tumors of central nervous
system in a single center.
Detailed description:
Clinical data of patients with germ-cell tumors of central nervous system who were
treated in the Department of Neuro-oncology, Sanbo Brain Hospital Capital Medical
University between January 2007 and December 2022 were retrospectively collected, and the
epidemiological and clinical characteristics, treatment, recurrence, prognosis and
prognostic factors of the disease were analyzed.
Criteria for eligibility:
Study pop:
Sanbo Brain Hospital, Capital Medical University
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Clinically or pathologically diagnosed as germ cell tumor of the central nervous
system.
- Have received antitumor therapy.
- Patients who were clinically diagnosed based on neuroimaging characteristics and
response to radiotherapy or chemotherapy were allowed for enrollment.
Exclusion Criteria:
- Patients with missing key information such as tumor location, surgical, chemotherapy
and radiotherapy data, and post-treatment evaluation.
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Sanbo Brain Hospital Capital Medical University
Address:
City:
Beijing
Country:
China
Start date:
June 1, 2023
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Beijing Sanbo Brain Hospital
Agency class:
Other
Source:
Beijing Sanbo Brain Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05836701
